|Opportunity||Production platform||Solution category||Value chain segment||Technology sector||Maturity level|
Scaffolding development for culinary and biomechanical requirements of cultivated seafood
A number of published studies have focused on scaffolds for cultivated meat (see Related Efforts) yet, to our knowledge, no studies have specifically attempted to formulate scaffolds for fish or…
|Cultivated||Commercial Research||R&D Raw Materials, Ingredients, & Inputs||Cell line development Scaffolding||0 – Complete whitespace|
“Rainbow roll 2.0” as a showcase product for cultivated seafood
Thin sheets of cultivated fish for layering on the outside of maki rolls and other sushi products could be an attractive market-entry commercial product. Producing thin sheets of tissue is…
|Cultivated||Commercial||End Products||End product formulation & manufacturing||0 – Complete whitespace|
Establishing intellectual property pooling frameworks
Intellectual property pools and patent pledges can help member companies contribute to a suite of patents that can be licensed within the pool.
|Cultivated Fermentation Plant-Based||Ecosystem||Business Services R&D||0 – Complete whitespace|
If you’d like to fund a research project, work on any of these solutions, share information about related efforts that are already underway, or elevate new ideas for advancing the alternative protein industry, we’d love to hear from you!
Explore key innovation priorities
Review commercial whitespaces, research gaps, technological needs, and investment priorities at each stage of the alternative protein value chain.
How we built this
Get an overview of GFI’s Solutions initiative and a summary of key resources.
Delve into the full report on the motivation, methodology, rationale, and key findings and recommendations of the Solutions initiative.
Explore our framework for uncovering second-order or third-order consequences and implications of hypothetical future scenarios to support better decision-making in the present.
Discover key findings from GFI’s premortem analysis of potential threats to the widespread adoption of alternative proteins, including strategies to avoid or mitigate the most pressing risks.